Hoboken

HOBOKEN, New Jersey and PHILADELPHIA, September 20, 2011 - Niiki Pharma Inc.

HOBOKEN, New Jersey and NEW YORK, July 14, 2011 - Prize Will Recognize Young Scientists Who Demonstrate Commitment to International Collaboration John Wiley & Sons, Inc., and Elsevier, two of the world's leading publishers of scholarly scientific knowledge, announced today their sponsorship of the APEC Science Prize for Innovation, Research and Education (ASPIRE Prize) to recognize young scientists who have demonstrated a commitment to both excellence in scientific research, as evidenced by scholarly publication, and cooperation with scientists from other Asia-Pacific Economic Cooperation (APEC) member economies.

HOBOKEN, New Jersey and PHILADELPHIA, June 1, 2011 - - Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming American Society of Clinical Oncology Annual Meeting Niiki Pharma announced today that it will present interim data from the ongoing Phase I clinical study for its lead product, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.

HOBOKEN, New Jersey, August 2, 2010 - Octapharma USA has received confirmation of orphan drug exclusivity from the U.S.